BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 33314745)

  • 1. Intracellular Activation of Anticancer Therapeutics Using Polymeric Bioorthogonal Nanocatalysts.
    Zhang X; Landis RF; Keshri P; Cao-Milán R; Luther DC; Gopalakrishnan S; Liu Y; Huang R; Li G; Malassiné M; Uddin I; Rondon B; Rotello VM
    Adv Healthc Mater; 2021 Mar; 10(5):e2001627. PubMed ID: 33314745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biodegradable nanoemulsion-based bioorthogonal nanocatalysts for intracellular generation of anticancer therapeutics.
    Nabawy A; Gupta A; Jiang M; Hirschbiegel CM; Fedeli S; Chattopadhyay AN; Park J; Zhang X; Liu L; Rotello VM
    Nanoscale; 2023 Aug; 15(33):13595-13602. PubMed ID: 37554065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biodegradable Antibacterial Bioorthogonal Polymeric Nanocatalysts Prepared by Flash Nanoprecipitation.
    Fedeli S; Huang R; Oz Y; Zhang X; Gupta A; Gopalakrishnan S; Makabenta JMV; Lamkin S; Sanyal A; Xu Y; Rotello VM
    ACS Appl Mater Interfaces; 2023 Mar; 15(12):15260-15268. PubMed ID: 36920076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymer-Based Bioorthogonal Nanocatalysts for the Treatment of Bacterial Biofilms.
    Huang R; Li CH; Cao-Milán R; He LD; Makabenta JM; Zhang X; Yu E; Rotello VM
    J Am Chem Soc; 2020 Jun; 142(24):10723-10729. PubMed ID: 32464057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Degradable ZnS-Supported Bioorthogonal Nanozymes with Enhanced Catalytic Activity for Intracellular Activation of Therapeutics.
    Zhang X; Lin S; Huang R; Gupta A; Fedeli S; Cao-Milán R; Luther DC; Liu Y; Jiang M; Li G; Rondon B; Wei H; Rotello VM
    J Am Chem Soc; 2022 Jul; 144(28):12893-12900. PubMed ID: 35786910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineered Polymer-Supported Biorthogonal Nanocatalysts Using Flash Nanoprecipitation.
    Huang R; Hirschbiegel CM; Zhang X; Gupta A; Fedeli S; Xu Y; Rotello VM
    ACS Appl Mater Interfaces; 2022 Jul; 14(28):31594-31600. PubMed ID: 35802797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modular Fabrication of Bioorthogonal Nanozymes for Biomedical Applications.
    Huang R; Hirschbiegel CM; Lehot V; Liu L; Cicek YA; Rotello VM
    Adv Mater; 2024 Mar; 36(10):e2300943. PubMed ID: 37042795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In situ activation of therapeutics through bioorthogonal catalysis.
    Wang W; Zhang X; Huang R; Hirschbiegel CM; Wang H; Ding Y; Rotello VM
    Adv Drug Deliv Rev; 2021 Sep; 176():113893. PubMed ID: 34333074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanomaterial-based bioorthogonal nanozymes for biological applications.
    Fedeli S; Im J; Gopalakrishnan S; Elia JL; Gupta A; Kim D; Rotello VM
    Chem Soc Rev; 2021 Dec; 50(24):13467-13480. PubMed ID: 34787131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. All-natural gelatin-based bioorthogonal catalysts for efficient eradication of bacterial biofilms.
    Nabawy A; Huang R; Luther DC; Zhang X; Li CH; Makabenta JM; Rotello VM
    Chem Sci; 2022 Oct; 13(41):12071-12077. PubMed ID: 36349111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inorganic nanoparticles as scaffolds for bioorthogonal catalysts.
    Hirschbiegel CM; Zhang X; Huang R; Cicek YA; Fedeli S; Rotello VM
    Adv Drug Deliv Rev; 2023 Apr; 195():114730. PubMed ID: 36791809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A DNA-Gated and Self-Protected Bioorthogonal Catalyst for Nanozyme-Assisted Safe Cancer Therapy.
    Zhang Y; Zhang L; Wang W; Deng Q; Liu M; Zhu Z; Liu H; Ren J; Qu X
    Angew Chem Int Ed Engl; 2023 Aug; 62(32):e202306395. PubMed ID: 37268594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioorthogonal nanozymes for breast cancer imaging and therapy.
    Zhang X; Liu Y; Doungchawee J; Castellanos-García LJ; Sikora KN; Jeon T; Goswami R; Fedeli S; Gupta A; Huang R; Hirschbiegel CM; Cao-Milán R; Majhi PKD; Cicek YA; Liu L; Jerry DJ; Vachet RW; Rotello VM
    J Control Release; 2023 May; 357():31-39. PubMed ID: 36948419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress in controllable bioorthogonal catalysis for prodrug activation.
    Liu X; Huang T; Chen Z; Yang H
    Chem Commun (Camb); 2023 Oct; 59(84):12548-12559. PubMed ID: 37791560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced Efficiency of Pd(0)-Based Single Chain Polymeric Nanoparticles for
    Deng L; Sathyan A; Adam C; Unciti-Broceta A; Sebastian V; Palmans ARA
    Nano Lett; 2024 Feb; 24(7):2242-2249. PubMed ID: 38346395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transition Metal Ru(II) Catalysts Immobilized Nanoreactors for Conditional Bioorthogonal Catalysis in Cells.
    Gao Z; Li Y; Xing J; Lu Y; Shao Q; Hu J; Zhao S; He W; Sun B
    ACS Appl Mater Interfaces; 2024 Apr; 16(13):15870-15878. PubMed ID: 38520329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioorthogonal nanozymes: an emerging strategy for disease therapy.
    Zhang Z; Fan K
    Nanoscale; 2022 Dec; 15(1):41-62. PubMed ID: 36512377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced Design of Gold Catalysts for Bioorthogonal Polyzymes.
    Hirschbiegel CM; Fedeli S; Zhang X; Huang R; Park J; Xu Y; Rotello VM
    Materials (Basel); 2022 Sep; 15(18):. PubMed ID: 36143797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rational Utilization of Black Phosphorus Nanosheets to Enhance Palladium-Mediated Bioorthogonal Catalytic Activity for Activation of Therapeutics.
    Rong M; Liu J; Sun Z; Li T; Li Y; Jiang C; Lu L
    Angew Chem Int Ed Engl; 2023 May; 62(19):e202216822. PubMed ID: 36917027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythrocyte-mediated delivery of bioorthogonal nanozymes for selective targeting of bacterial infections.
    Gupta A; Das R; Makabenta JM; Gupta A; Zhang X; Jeon T; Huang R; Liu Y; Gopalakrishnan S; Milán RC; Rotello VM
    Mater Horiz; 2021 Nov; 8(12):3424-3431. PubMed ID: 34700339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.